Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 28:16:7339-7348.
doi: 10.2147/IDR.S433815. eCollection 2023.

The Efficacy and Safety of Shashen-Maidong Decoction Combined with Western Medicine in the Treatment of Omicron Infected Individuals Over 85 Years Old: A Retrospective Study

Xiao-Xi Lin #  1 , Yu-Qi Yin #  2 , Wen-Zheng Zhang  3 , Jia-Huan Huang  4 , Wei-Shang Hu  1
Affiliations

The Efficacy and Safety of Shashen-Maidong Decoction Combined with Western Medicine in the Treatment of Omicron Infected Individuals Over 85 Years Old: A Retrospective Study

Xiao-Xi Lin et al. Infect Drug Resist. .

Abstract

Background: During the Omicron variant outbreak of COVID-19 (2022-2023), Chinese healthcare institutions combined traditional Chinese medicine (TCM) with Western medical practices to treat COVID-19 patients, especially the elderly. The efficacy and safety of this approach, especially for individuals aged over 85, need further investigation.

Methods: In this retrospective study, a cohort of 62 patients aged over 85 years, diagnosed with COVID-19 infection, was examined. Among them, 34 patients were administered Shashen-Maidong decoction in conjunction with Western medicine (SMD+WM group), while the remaining 28 patients received only Western medicine (WM group). Comparative analysis was conducted between the two groups, encompassing parameters such as the duration for the nucleic acid test to turn negative, length of intensive care unit (ICU) stay, mortality rate, utilization of high-flow nasal cannula oxygen (HFNC), occurrence of endo-tracheal intubation, frequency of recurrent respiratory infections within three months, and various laboratory indicators.

Results: There were no significant differences observed between the two groups in terms of the duration for the nucleic acid test to turn negative, the length of ICU stay, mortality rate, utilization of HFNC, performance of endo-tracheal intubation, or the frequency of recurrent respiratory infections within three months (P > 0.05). However, in comparison to the WM group, the SMD+WM group exhibited notably lower growth rates in white blood cell (WBC) and neutrophil (NEUT) values. Additionally, the SMD+WM group demonstrated superior improvement in cardiac troponin I (cTnI) and B-type natriuretic peptide (BNP) values.

Conclusion: In contrast to the administration of Western medicine alone, the combined use of Shashen-Maidong decoction with Western medicine significantly suppresses the increase in WBC count, particularly in NEUT levels, in elderly patients diagnosed with COVID-19. Moreover, this combined treatment exhibits a protective effect on cardiac function and demonstrates a relatively safe profile.

Keywords: COVID-19; Shashen-Maidong decoction; traditional Chinese medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests for this work.

Figures

Figure 1
Figure 1
Patient recruitment flow diagram.
Figure 2
Figure 2
Variation rate at week 2 compared to the baseline and week 1 (Only laboratory indicators with significant differences between groups are listed). *Comparison of the variation rate between week 2 and week 1.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Ross JA, Malone PK, Levy S. The impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on substance use in the United States. Clin Infect Dis. 2022;75(Supplement_1):S81–S85. doi:10.1093/cid/ciac311 - DOI - PMC - PubMed
    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648 - DOI - PubMed
    1. Vitiello A, Ferrara F, Auti AM, Di Domenico M, Boccellino M. Advances in the omicron variant development. J Intern Med. 2022;292(1):81–90. doi:10.1111/joim.13478 - DOI - PMC - PubMed
    1. Chavda VP, Apostolopoulos V. Omicron variant (B.1.1.529) of SARS-CoV-2: threat for the elderly? Maturitas. 2022;158:78–81. doi:10.1016/j.maturitas.2022.01.011 - DOI - PMC - PubMed
    1. Peng Y, Guo Y, Zhang H, et al. Clinical characteristics and analysis of risk factors for disease progression of patients with SARS-CoV-2 omicron variant infection: a retrospective study of 25,207 cases in a Fangcang hospital. Front Cell Infect Microbiol. 2022;12:1009894. doi:10.3389/fcimb.2022.1009894 - DOI - PMC - PubMed